ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025.

The idea of self-amplifying gene editing is to get cells to pass on packages of CRISPR machinery to their neighbours, boosting the effect ...

CRISPR Therapeutics (NASDAQ:CRSP) is a gene editing company that develops gene-based medicines for serious human diseases ...

DNA is often described as the instruction manual for building the fundamental components of life. Proteins are helpers that ...

Purdue researchers identify the PACT protein as a potential target for triple-negative breast cancer, opening new paths for future treatments.

A Purdue University team led by Kyle Cottrell has discovered a new therapeutic target for triple-negative breast cancer.

A graphic representation of a round, lumpy, blue protein and a single, comblike, purple strand of RNA interacting with a twisted, double, blue strand of DNA that separates where it meets the RNA. A ...

Abstract: Nanopore sequencing technology is an emerging method for achieving long sequence reads on single DNA molecules without prior sample amplification. Detection involves changes in current ...

Everyone seems to be talking about protein right now—and for good reason. “Protein is the building block of every tissue in our body, from muscles and bones to organs, skin, and hair,” says Rachel ...

Genome editing has been a long goal in molecular biology, medicine, and biotechnology, dating back to the discovery of restriction enzymes. However, the identification of zinc-finger nucleases (ZFN) ...